Lv11
30 积分 2022-01-24 加入
文献找起来
GPCR drug discovery: new agents, targets and indications
42分钟前
待确认
Unlocking the mechanisms underlying the activity of pembrolizumab plus enfortumab vedotin in patients with urothelial carcinoma
7天前
已完结
The enedioic acid analog 326E alleviates metabolic dysfunction-associated steatohepatitis via dual targeting at ACLY and PPARα
1个月前
已完结
Current and emerging strategies for subcutaneous delivery of high-concentration and high-dose antibody therapeutics
1个月前
已完结
Understanding the chemistry & pharmacology of antibody–drug conjugates in triple-negative breast cancer with special reference to exatecan derivatives
2个月前
已完结
Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex
4个月前
已关闭
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
4个月前
已完结
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression
5个月前
已完结
TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
7个月前
已完结
The TL1A inhibitors in IBD: what’s in the pot?
7个月前
已完结
Transcriptome profiling of human pluripotent stem cell-derived cerebellar organoids reveals faster commitment under dynamic conditions
皖公网安备34019202002308
